戻る Agenda
Session 6 Track 2 - Communications: Making Clinical Trial Information More Available: Why..What..and How?
Session Chair(s)
Paul Litowitz, MBA, RAC
Manager, Public and Regulatory Affairs Outreach Section
Health Canada, Canada
Making clinical trial information publicly accessible in registries has been identified as a key means of enhancing transparency. Various organizations, domestic and international, are currently engaged in initiatives to encourage or require registration and disclosure of clinical trial information. Regulators, industry, industry associations, medical journals, public funding agencies, patient groups and the World Health Organization (WHO) have all initiated efforts to promote transparency of clinical trials. Currently, there is no formal consensus on international norms and standards for reporting the findings of clinical trials. Clinical trial medical informatics aims to achieve the best possible support of patient care and outcome by acquiring, generating and sharing ongoing in trial information. Attend this session to learn more about the developing policy and initiatives as well as current practices and case studies in regard to enhancing health professional and public access to important therapeutic product information.
Speaker(s)
Saving Lives and Reducing Waste: Update on Sharing of Clinical Trial Information
An-Wen Chan, MD, PhD, FRCPC
University of Toronto, Women's College Hospital, Canada
Professor, Dept of Medicine and Phelan Senior Scientist, WCRI
New Clinical Trial Data Base
Joel Raymond
Health Canada, Canada
Manager
Clinical Trials Information at the Research Centre Level
Andrew Arnold
Escarpment Cancer Research Institute, Canada
Head of Clinical Trials